A Thorough QT Study of Aticaprant (JNJ-67953964) in Healthy Adult Participants
Clinical trial NCT05387759 · COMPLETED
Trial details
- NCT number
- NCT05387759
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-30
- Primary completion
- 2022-10-04
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.